Molecular characterization of prostate cancer following androgen deprivation: the devil in the details

Affiliations

¹ Department of Urology, Weill Medical College of Cornell University, New York, NY, USA; Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York, NY, USA. Electronic address: chb9074@med.cornell.edu.
² Department of Urology, Weill Medical College of Cornell University, New York, NY, USA; Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York, NY, USA; Institute for Precision Medicine of Weill Medical College and New York-Presbyterian Hospital, New York, NY, USA.

Editorial

Christopher E Barbieri et al. Eur Urol. 2014 Jul.

. 2014 Jul;66(1):40-1.

doi: 10.1016/j.eururo.2013.08.056. Epub 2013 Aug 30.

¹ Department of Urology, Weill Medical College of Cornell University, New York, NY, USA; Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York, NY, USA. Electronic address: chb9074@med.cornell.edu.
² Department of Urology, Weill Medical College of Cornell University, New York, NY, USA; Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York, NY, USA; Institute for Precision Medicine of Weill Medical College and New York-Presbyterian Hospital, New York, NY, USA.

No abstract available

Comment on

Next-generation sequencing of advanced prostate cancer treated with androgen-deprivation therapy.
Rajan P, Sudbery IM, Villasevil ME, Mui E, Fleming J, Davis M, Ahmad I, Edwards J, Sansom OJ, Sims D, Ponting CP, Heger A, McMenemin RM, Pedley ID, Leung HY. Rajan P, et al. Eur Urol. 2014 Jul;66(1):32-9. doi: 10.1016/j.eururo.2013.08.011. Epub 2013 Aug 14. Eur Urol. 2014. PMID: 24054872 Free PMC article.